Monash Cardiac Rhythm Management Department, MonashHeart, Monash Medical Centre, Melbourne, Australia.
Monash Cardiovascular Research Centre, MonashHeart, Monash Medical Centre and Monash University, Melbourne, Australia.
Catheter Cardiovasc Interv. 2018 Oct 1;92(4):777-782. doi: 10.1002/ccd.27463. Epub 2018 Jan 4.
To determine permanent pacemaker (PPM) dependency following transcatheter aortic valve replacement (TAVR) with the Lotus valve system (Boston Scientific), and the impact of PPM implantation on long-term morbidity and mortality.
Conduction abnormalities are among the most common complications following TAVR. Limited studies have assessed pacing dependency following TAVR.
Consecutive patients (n = 166) with severe aortic stenosis who underwent TAVR with the Lotus valve system were prospectively recruited from a single-center. PPMs were implanted according to standard clinical criteria. Patients were followed in-hospital and at 1, 3, 6, and 12 months to determine pacemaker dependency and clinical outcomes.
Fourteen patients with a pre-existing PPM (8%) were excluded with the remaining 152 patients aged 83.6 ± 5.6 years and 46% male. PPMs were implanted 3.8 ± 4 days post-TAVR in 38/152 patients (25%). Indication for PPM was complete heart block in 29 (76%) of patients. At 30-day and one-year follow up, 57% and 38% of patients were pacemaker dependent, respectively. The mean ventricular pacing percentage decreased in the first three months after PPM implantation and remained relatively stable after that.
Only 38% of Lotus recipients who require a PPM following TAVR with the Lotus valve remain pacing dependent at one year.
确定经导管主动脉瓣置换术(TAVR)后使用 Lotus 瓣膜系统(波士顿科学公司)植入永久性起搏器(PPM)的依赖情况,以及 PPM 植入对长期发病率和死亡率的影响。
传导异常是 TAVR 后最常见的并发症之一。有限的研究评估了 TAVR 后起搏依赖情况。
前瞻性地从一家单中心招募了 166 名患有严重主动脉瓣狭窄且接受 Lotus 瓣膜系统 TAVR 的连续患者。根据标准临床标准植入 PPM。患者在住院期间和 1、3、6 和 12 个月时进行随访,以确定起搏器依赖和临床结果。
排除了 14 名术前已安装 PPM(8%)的患者,剩余 152 名患者年龄为 83.6±5.6 岁,46%为男性。在 38/152 名患者(25%)中,在 TAVR 后 3.8±4 天植入了 PPM。植入 PPM 的指征是 29 名患者(76%)完全性心脏阻滞。在 30 天和一年随访时,分别有 57%和 38%的患者依赖起搏器。在 PPM 植入后的前三个月,心室起搏百分比降低,此后相对稳定。
在使用 Lotus 瓣膜进行 TAVR 后需要 PPM 的 Lotus 瓣膜系统接受者中,只有 38%在一年后仍依赖起搏器。